
Q-Line Biotech IPO Allotment Expected to be Finalized Today

Q-Line Biotech
IPOQ-Line Biotech IPO Allotment to be Finalized on 26 May
The allotment of Q-Line Biotech IPO, which opened for subscription on 21 May and closed on 25 May, is set to be finalized on Tuesday, 26 May. The shares of Q-Line Biotech IPO will make their debut on the National Stock Exchange (NSE) Small and Medium Enterprises (SME) platform on 29 May.
Q-Line Biotech is a company engaged in the development, manufacturing, and marketing of reagents, including kits, point-of-care (POC) devices, and consumables. The company also manufactures and distributes diagnostic equipment catering to healthcare diagnostic requirements. Its major manufacturing segments comprise indigenous production of reagents across haematology, clinical chemistry, immunodiagnostics, molecular diagnostics, and other categories such as POC devices and rapid tests, as well as the manufacturing and supply of in-vitro diagnostics (IVD), pathology equipment, and related devices.
Grey Market Premium
Read also: SMR Jewels IPO Successfully Lists with Institutional Support
The shares of Q-Line Biotech IPO are commanding a strong premium in the grey market. According to Investorgain, the grey market premium (GMP) of Q-Line Biotech IPO is ₹115. This means that the estimated listing price of Q-Line Biotech IPO is likely to be ₹458, which is 33.53% higher than the IPO price of ₹343.
Allotment Status
The allotment of the Q-Line Biotech IPO is likely to be finalized on Tuesday, 26 May. Investors can check their allotment status on the NSE website or on the official allotment page of Purva Sharegistry (India) Pvt. Ltd, the registrar of the issue.
How to Check Allotment Status
Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO
To check the allotment status of the Q-Line Biotech IPO, investors can follow these steps:
- Visit the NSE IPO status page.
- Select "Equity & SME IPO bid details".
- Choose "Q-Line Biotech" with the symbol "QLINE".
- Enter your PAN number and application number.
- Click on the "Submit" button.
Alternatively, investors can visit the official allotment page of Purva Sharegistry (India) and follow these steps:
- Select 'Q-Line Biotech' from the IPO list.
- Enter either your PAN number or application number.
- Click on the 'Search' button.
IPO Details
The ₹214.48 crore IPO comprised solely a fresh issue of 62.53 lakh equity shares and did not include any offer-for-sale (OFS) portion. The proceeds from the issue will be utilized towards working capital needs, repayment of debt, and general corporate requirements. The IPO was priced in the range of ₹326–₹343 per share, with one lot comprising 400 shares. Retail investors were required to bid for a minimum of two lots, equivalent to 800 shares.
Subscription Status
The Q-Line Biotech IPO subscription status was 102 times on the last day. The retail portion was subscribed at 71.44x, the Non Institutional Investor (NII) portion was booked at 145.98x, and the Qualified Institutional Buyers (QIBs) portion received 123.94x bidding, according to Chittorgarh.
| Category | Subscription Status |
|---|---|
| Retail Portion | 71.44x |
| Non Institutional Investor (NII) Portion | 145.98x |
| Qualified Institutional Buyers (QIBs) Portion | 123.94x |
Investor Takeaway
Investors should be prepared for the potential listing of Q-Line Biotech IPO on NSE SME on 29 May.
More in IPO

SMR Jewels IPO Successfully Lists with Institutional Support

Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Merritronix IPO Sees Robust Subscription, Oversubscribed by 293 Times on Final Day
